COVID-19 Returns: Updated Symptoms, Vaccination Strategies, and Myths in a Changing Landscape
After a long hiatus caused by war and economic crises, COVID-19 has once again become a pressing concern for Ukrainians.
While many have forgotten about the virus or view it with skepticism, official statistics indicate an increase in cases.
According to the Ukrainian Center for Public Health, from September 1 to 7, the country recorded over 14,000 new positive COVID-19 tests, reflecting a 32.3% rise compared to the previous week, which had about 10,600 cases.
Comparing these figures with data from previous years, it becomes evident that newer virus strains are more contagious, although the mortality rate remains relatively low — only a few hundred deaths per week nationwide.
Nonetheless, it’s crucial to recognize that actual infection rates might be underestimated due to home testing and underreporting.
Such trends compel medical professionals and experts to stay vigilant, as COVID-19 symptoms can be unpredictable, and complications may pose serious health risks.
The latest strains, such as the Omicron subvariant XFG (Stratus), have been confirmed in 225 cases across Ukraine, indicating ongoing viral evolution.
Typical symptoms like fever, cough, fatigue, and loss of taste or smell still dominate, but new signs such as hoarseness and vocal changes are gaining attention, especially in severe cases marked by shortness of breath, speech disturbances, or chest pain.
Confirmatory testing, either through PCR in healthcare facilities or rapid home tests, remains the primary diagnostic method.
Vaccination continues to be the most effective shield— presently, Ukraine offers several vaccines, including mRNA-based options like Pfizer’s COMIRNATY, suitable for various age groups, from infants to seniors.
Vaccinating vulnerable populations—elderly, immunocompromised, or those with chronic illnesses—is particularly vital, with booster doses recommended every 6–12 months.
Pregnant women are advised to get vaccinated at any stage of pregnancy, ideally during the second trimester.
Preventive measures such as mask-wearing, proper ventilation, hand hygiene, and maintaining physical distance are essential.
Medical experts warn against unproven treatments and false cures; in particular, medications like Paxlovid should only be used under medical supervision, especially as their misuse can cause harm.
Regarding symptom management, the consensus remains: fever over 38°C warrants medication, but individual comfort and physician advice are paramount.
The ubiquitous use of anti-inflammatory drugs like Ibuprofen without proper indication can do more damage than good.
The effectiveness of antivirals such as Amixin or Groprinosin remains scientifically unproven, and their potential to worsen cytokine storms is not well established.
After recovering from COVID-19, some patients experience long-term effects—early detection through targeted testing is crucial if symptoms persist or worsen.
However, there is no universal set of tests necessary post-infection; each case should be evaluated individually.
The key message remains: be vigilant, take responsibility for your health, and seek medical advice promptly if you suspect complications.